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Abstract 25	
 26	
In recent years, solving protein structures by single particle cryogenic electron microscopy 27	
(cryoEM) has become a crucial tool in structural biology. While exciting progress is being made 28	
towards the visualization of smaller and smaller macromolecules, the median protein size in both 29	
eukaryotes and bacteria is still beyond the reach of single particle cryoEM. To overcome this 30	
problem, we implemented a platform strategy in which a small protein target was rigidly 31	
attached to a large, symmetric base via a selectable adapter. Seven designs were tested. In the 32	
best construct, a designed ankyrin repeat protein (DARPin) was rigidly fused to tetrameric rabbit 33	
muscle aldolase through a helical linker. The DARPin retained its ability to bind its target, the 27 34	
kDa green fluorescent protein (GFP). We solved the structure of this complex to 3.0 Å resolution 35	
overall, with 5 to 8 Å resolution in the GFP region. As flexibility in the DARPin limited the 36	
overall resolution of the target, we describe strategies to rigidify this element.  37	
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Author summary 52	
 53	
Single particle cryogenic electron microscopy (cryoEM) is a technique that uses images of 54	
purified proteins to determine their atomic structure. Unfortunately, the majority of proteins in 55	
the human and bacterial proteomes are too small to be analyzed by cryoEM. Over the years, 56	
several groups have suggested the use of a platform to increase the size of small protein targets. 57	
The platform is composed of a large protein base and a selectable adapter that binds the target 58	
protein. Here we report a platform based on tetrameric rabbit muscle aldolase that is fused to a 59	
Designed Ankyrin Repeat Protein (DARPin). Phage display libraries can be used to generate 60	
DARPins against target proteins.  The residues mutated in a phage display library to generate a 61	
DARPin against a new target do not overlap with the DARPin-base fusion in the platform, thus 62	
changing the DARPin identity will not disrupt the platform design.  The DARPin adapter used 63	
here is capable of binding Green Fluorescent Protein (GFP). We report the structure of GFP to 5 64	
to 8 Å local resolution by single particle cryoEM. Our analysis demonstrates that flexibility in 65	
the DARPin-aldolase platform prevents us from achieving higher resolution in the GFP region. 66	
We suggest changes to the DARPin design to rigidify the DARPin-aldolase platform. This work 67	
expands on current platforms and paves a generally applicable way toward structure 68	
determination of small proteins by cryoEM.  69	
 70	
 71	
 72	
 73	
 74	
 75	
 76	
 77	
 78	
 79	
 80	
 81	
 82	
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/455063doi: bioRxiv preprint first posted online Oct. 30, 2018; 
 4 
Introduction 83	
 84	
Single particle cryoEM can reveal the structures of large macromolecular complexes to near 85	
atomic resolution. To solve a protein structure by single particle cryoEM, purified proteins are 86	
rapidly frozen in a thin layer of vitreous ice. A transmission electron microscope is used to 87	
collect projection images of the protein. Individual proteins are identified in the ice and their 88	
orientations are computationally determined. The projection images are then combined to 89	
calculate a 3D reconstruction of the protein.  90	
 91	
A fundamental challenge in single particle cryoEM is that small proteins do not produce enough 92	
contrast in noisy projection images to precisely determine their orientation. Richard Henderson 93	
estimated that with ideal images, a 3 Å structure could be reconstructed for a 40 kDa protein (1). 94	
Unfortunately, real electron micrographs are imperfect so this theoretical minimum of 95	
macromolecular size has never been reached. The smallest protein to be solved to near atomic 96	
resolution so far by cryoEM is hemoglobin (64 kDa) (2), but the median protein lengths in both 97	
bacteria (27 kDa) and eukaryotes (36 kDa) are about two times smaller (3). Consequently, many 98	
proteins in biology are beyond the reach of high-resolution structure determination by single 99	
particle cryoEM.  100	
 101	
Over the years, several strategies to overcome the size limit problem in single particle cryoEM 102	
have been suggested. Two major themes have emerged to increase the target mass and improve 103	
its orientation determination. First, the target can be decorated with antibody fragments (6) (7).  104	
Second, the target can be rigidly attached to a large platform protein. The platform is typically 105	
composed of a base protein and an adapter. The purpose of the base protein is to increase the 106	
molecular weight, which facilitates accurate particle picking and precise particle orientation 107	
determination. The adapter can be customized (a covalent fusion between the target and the base) 108	
or general (a selectable adapter that facilitates non-covalent binding of the target to the platform 109	
base). Covalent approaches have utilized direct fusions between the target protein and the base 110	
either via a flexible linker adapter (4) or a helical junction adapter (5) (8).  For the platform to be 111	
successful, the adapter must be rigidly attached to the base. The flexible linker adapter was 112	
therefore insufficient to determine the structure of the target (4), but the use of a helix-forming 113	
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peptide linker (8)(9) or direct concatenation of two helices  (5)(10) has shown promise. Most 114	
recently, Liu et al. demonstrated that a rigid, continuous α-helix could be formed by linking the 115	
terminal α-helices of a designed ankyrin repeat protein (DARPin) and a nanocage subunit 116	
through a helix-forming peptide linker (9) (8). Notably, Liu et al were able to show the structure 117	
of the 17 kDa DARPin to 3.5 to 5 Å local resolution (8). Unfortunately, these strategies are 118	
limited to target proteins with a terminal α-helix, and their implementation requires that the 119	
length of the helical junction adapter must be customized for each new target.  Utilizing a non-120	
covalent platform strategy with a selectable adapter (like an antibody or a DARPin) has the 121	
potential to be generally applicable, regardless of the structure of the target, since the selectable 122	
adapter could be raised against any target using phage display, while the invariant nature of the 123	
adapter framework region would allow the one-time optimization of a rigid attachment point 124	
between it and the base. Along these lines, Liu et al. suggested that their DARPin-nanocage 125	
could display a small protein for structure determination by cryoEM (8), but so far no group has 126	
demonstrated this.    	127	
 128	
Here we report the outcomes of a variety of new designs and report the structure of the first small 129	
protein visualized through a base/selectable-adapter platform approach.  130	
 131	
Results 132	
 133	
Platform strategy and design 134	
The goal of our study was to design a generally applicable platform to solve small protein 135	
structures by single particle cryoEM. We explored several candidate base proteins and selectable 136	
adapters (Fig S1). We favored bases that were easy to purify and that had already been solved to 137	
high-resolution by single particle cryoEM. We reasoned that oligomeric and symmetric (as a 138	
globular protein, or as a helical tube) bases would be best.  139	
 140	
As selectable adapters, we first considered antibody fragments (Fabs and scFvs). Fabs have a 141	
flexible elbow connecting two immunoglobulin regions, whereas scFvs are made up of one 142	
immunoglobulin region.  The Fab elbow could introduce flexibility, so we preferred the smaller, 143	
more compact scFv. However, because the beta sandwich immunoglobulin fold of a scFv could 144	
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be difficult to rigidly fuse to the surface of a platform base, we identified Staphylococcus Protein 145	
A (PrA) as a linker that could bind the invariant region of a scFv (11). As PrA is a three-helix 146	
bundle, we reasoned that it could be rigidly attached to a base via a helical linker. Thus in one of 147	
our designs, the C-terminal helix of PrA was fused to the N-terminal helix of the base protein. 148	
Since PrA is capable of binding the invariant scFv framework, the base-PrA:scFv interfaces 149	
would not need to be redesigned for each new target.  Unfortunately, in our biochemical 150	
experiments, we observed that the PrA:scFv interaction did not remain stable through a gel 151	
filtration column, indicating that the binding affinity was not strong enough for our purposes. 152	
Further mutagenesis to the PrA:scFv interface may strengthen the interaction. Regardless, a 153	
fundamental concern with this design is that two non-covalent binding interactions are required 154	
(PrA:scFv, and scFv:target), which could lead to occupancy issues. As a result, we moved to 155	
DARPins as our selectable adapter (Fig 1B).  156	
 157	
In our designs, the final alpha helix of the DARPin C-terminal cap (C-cap) was directly fused to 158	
the first α-helix of the base (Fig 1C). All DARPin libraries use a C-cap to stabilize the protein, so 159	
we expect it will be straightforward to swap in any DARPin built on the same framework (Fig 160	
1B). In the base-DARPin platform design, only one non-covalent interaction is required 161	
(between the DARPin and the target), which results in a more predictable and stable complex. 162	
We chose a DARPin that formed a stable complex with GFP as a first test case (12) and screened 163	
several base-DARPin candidates.  164	
 165	
Screening base candidates 166	
We performed expression trials for five of our base-DARPin candidates (Fig S1). These bases 167	
included β-galactosidase (β-gal) (13), the vipA/vipB helical tube (14), the E. coli ribosome (15), 168	
TibC (16), and aldolase (17).  169	
 170	
Because β-gal tetramerization requires the N- and C-termini of each subunit (18), an internal 171	
DARPin insertion was used, flanked by a helix-forming peptide (at the DARPin N-cap) and a 172	
flexible linker (at the DARPin C-cap) (9). Biochemically the ß-gal-DARPin platform formed a 173	
stable complex with GFP, but no cryoEM density was observed for the DARPin or GFP in our 3 174	
Å reconstruction. This means that the helical linker was flexible relative to the β-gal base.  175	
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 176	
We therefore focused on bases with a terminal α-helix that could be rigidly fused to the DARPin. 177	
The vipA/vipB, ribosome L29, TibC, and aldolase proteins all had long terminal α-helices to 178	
facilitate direct fusion. In our experiments, the helical tube vipA-DARPin/vipB platform 179	
exhibited poor expression in E. coli, while the L29-PrA fusion did not integrate well into ∆L29 180	
E. coli ribosomes (15) (Fig S1). The purified TibC-DARPin platform formed a stable complex 181	
with GFP, but the complex demonstrated aggregation and preferred orientation on plunge frozen 182	
grids. In contrast, the DARPin-aldolase platform was well-behaved.  183	
 184	
In our DARPin-aldolase platform, the C-terminal α-helix of the DARPin was directly 185	
concatenated to the N-terminal α-helix of aldolase (Fig 1C) (S2 Fig A). The D2 symmetry of the 186	
DARPin-aldolase platform provided extensive space for the target and could potentially 187	
accommodate a globular protein of up to 740 kDa without steric clash (Fig 1E, 1F) (S1 Movie). 188	
The purified GFP:DARPin-aldolase complex was stable in a gel filtration column with an 189	
apparent 1:1 stoichiometry of DARPin-aldolase to the target (GFP) (S2 Fig B and C).  190	
 191	
CryoEM analysis of the GFP:DARPin-aldolase complex 192	
To solve the structure of GFP bound to the DARPin-aldolase platform, we collected 1,681 193	
micrographs on a Titan Krios (Fig S3). Because the thin ice forced a slight preferred orientation 194	
issue, an additional 1,180 micrographs were collected at 26˚ tilt (see methods) (19). High quality 195	
micrographs were selected after CTF correction (Fig S4) and particles were autopicked in Relion 196	
(Fig S3). After 2D classification in cryoSPARC, classes with strong secondary structure were 197	
selected for reconstruction. The GFP:DARPin-aldolase complex reconstruction yielded an 198	
overall resolution of 3 Å with C1 symmetry (Fig S5B). Further classification suggested too much 199	
conformational heterogeneity to apply D2 symmetry. The aldolase core and the helical linker 200	
were resolved to near atomic resolution (Fig 2B, 2C, 2D). The DARPin and GFP exhibited a 201	
local resolution of 4 to 8 Å, with discontinuous regions of higher resolution of 3.5 Å (Fig 2D) 202	
(S2 Movie). Although the resolution in the GFP and DARPin portion was not sufficient to build 203	
a model or assign sequence de novo, the static X-ray structures of GFP and the DARPin could be 204	
reliably docked into the map (Fig 2A).   205	
 206	
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DARPin framework caused conformational heterogeneity  207	
Because of the 5 to 8 Å local resolution range in the GFP portion of the map (Fig 2D), we 208	
suspected that part of the GFP:DARPin-aldolase complex was flexible. To better understand the 209	
conformational heterogeneity in the data, a mask was generated around a single DARPin/GFP 210	
unit and Relion particle symmetry expansion was used to consider each subunit individually (Fig 211	
3A, Fig S3) (21). The symmetry expanded particles were subjected to 3D classification without 212	
alignment, a strategy in which the orientation parameters determined in the previous refinement 213	
are used to classify the particles into subsets. For this focused classification, a spherical mask 214	
that encompassed the aldolase surface was used to increase the signal. The resulting five classes 215	
showed reasonable GFP:DARPin conformations (Fig 3B), but subsequent refinements were still 216	
limited to 5 to 6 Å overall, which suggested that additional conformational heterogeneity 217	
remained within the subsets. The majority of the particles (54%) were classified into class 2 218	
(yellow), which appeared to lack a DARPin (Fig 3B). Class 2 was subjected to an additional 219	
round of 3D classification where it revealed several reasonable but lower resolution 220	
GFP:DARPin conformations (Fig S6). To investigate the heterogeneity in the focused classes, 221	
we compared each class to class 4 (Fig 3C, 3D). In the different classes, the GFP:DARPin 222	
density shows a clear rocking around the Y axis (Fig 3C) and around the Z axis (Fig 3D) relative 223	
to the aldolase base. At this point, we wondered if any these displacements could be attributed to 224	
the aldolase subunit. We performed a similar focused classification experiment with a mask 225	
around the aldolase subunit and the helical linker, but no rotation or shift was observed in the 226	
resulting subsets (data not shown). Thus, we concluded that the displacement likely arose in the 227	
C-cap second helix that is fused into the helical linker, and other regions of the DARPin distal to 228	
the linker.  229	
 230	
Discussion 231	
 232	
In this study, we designed and tested a variety of platforms capable of non-covalently binding a 233	
small target protein via a selectable adapter for structure determination by single particle 234	
cryoEM. In our best construct, we resolved our target protein (GFP) to 5 to 8 Å resolution.  235	
 236	
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Our DARPin-aldolase platform has several advantages over other strategies. It is simple to 237	
express and purify. Aldolase has D2 symmetry and allows attachment of four targets without 238	
steric clash. Aldolase can be reconstructed to 2.6 Å resolution with even a 200 keV microscope 239	
(17). Because DARPins can be readily generated against a wide range of small protein targets, 240	
the attachment of a DARPin to aldolase promises to be a generally applicable strategy. A recent 241	
study of the insulin degrading enzyme (IDE) bound to Fabs was able to isolate several IDE 242	
conformations using different Fabs (22). It stands to reason that different DARPins could also 243	
stabilize different conformations of the target. Because switching DARPins in the platform 244	
would be done by straight-forward DNA manipulations, our DARPin-aldolase platform has the 245	
potential to resolve a series of conformations of the target protein. 246	
 247	
Our biochemistry experiments suggested that the purified GFP:DARPin-aldolase complex was 248	
very stable, and clear secondary structure was apparent in the 2D classes, yet heterogeneity 249	
remained. Because the aldolase base and the helical linker region were resolved to near atomic 250	
resolution (Fig 2B and 2C), the heterogeneity likely began in the DARPin C-cap. The DARPin 251	
against GFP used here was from a first generation DARPin library. The C-cap of the first 252	
generation DARPins was reported to be less stable than the other repeat modules (23). While the 253	
crystal structure contained a well-resolved C-cap, the heterogeneity observed here suggests that 254	
it is not yet sufficiently rigid to serve as an attachment point in a cryoEM platform (Fig 3). 255	
Recent DARPin phage display libraries contain DARPins with reduced surface entropy and a 256	
more stable C-cap sequence (23), however, and additional stabilizing surface interactions could 257	
be introduced in future designs (28) (29), or even a second attachment point of the DARPin to 258	
the base (at both N- and C-terminal caps of DARPin for instance). Together such improvements 259	
could allow the DARPin-aldolase platform to reveal the structures of many small proteins to near 260	
atomic resolution. 261	
 262	
Materials and Methods 263	
 264	
Computational design 265	
Computational α-helix fusion was generated by manually docking the rabbit muscle aldolase 266	
structure (PDB code: 5VY5) and GFP/DARPin complex (PDB code: 5MA6). In order to rigidly 267	
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join the aldolase and DARPin moiety together, we truncated the C-terminal flexible loop on 268	
DARPin and N-terminal flexible loop on aldolase, respectively, exposing the two terminal α-269	
helices. The two terminal α-helices were manually concatenated and joined together to form an 270	
ideal α-helix using building α-helix tool in UCSF Chimera (30). The model was inspected for the 271	
orientation of DARPin relative to the aldolase, ensuring no steric clash and the providing enough 272	
space for target protein attachment. All structural design figures were generated using 273	
PyMOL1.8 (https://pymol.org).  274	
 275	
Cloning, protein expression, and purification of the recombinant DARPin-aldolase platform and 276	
GFP 277	
The DARPin sequence was DARPin 3G86.32 (Fig S2A) (12). The cDNA expressing GFP and 278	
our DARPin-aldolase fusion were synthesized at IDT DNA company. The cDNA of GFP and 279	
DARPin-aldolase fusion were PCR-amplified and inserted into pACYCDuet and pET21b vector 280	
for recombinant expression in E. coli, producing no-tag GFP protein and C-terminal His-tag of 281	
DARPin-aldolase chimeric fusion. GFP and DARPin-aldolase were coexpressed in E. coli 282	
BL21(DE3) (Lucigen) using autoinduction medium with trace elements (Formedium) at 30 °C 283	
for overnight. Cells were harvested by centrifugation and the protein complex was then purified 284	
with Ni-NTA affinity chromatography (Qiagen), and Superdex 200 chromatography (GE 285	
healthcare). The purified GFP-DARPin-aldolase complex was concentrated to 2.5mg/ml in a 286	
buffer containing 25 mM Tris-HCl pH 8.0 and 150 mM NaCl.  287	
 288	
CryoEM sample preparation and data collection  289	
Electron microscopy grids were prepared at Scripps Research Institute. Briefly, 3 µL sample of 290	
2.5 mg/ml GFP-DARPin-aldolase complex was applied to a plasma cleaned Au UltraFoil Grid 291	
(300 Mesh, R2/2, Quantifoil) in a cold room (4˚C, ≥95% relative humidity). The grid was 292	
manually blotted with a filter paper (Whatman No.1) for approximately 3 seconds before 293	
plunging into liquid ethane using a manual plunger (17). The grids were screened in Talos 294	
Arctica 200 kV with Falcon 3 (FEI) direct electron detector for ice thickness and sample 295	
distribution. Micrographs of GFP-DARPin-aldolase complex were collected on Titan Krios 296	
microscope (FEI) operating and 300 kV with energy filter (Gatan) and equipped with a K2 297	
Summit direct electron detector (Gatan). For untilted data, Serial EM was used for automated 298	
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EM image acquisition (31). After calculating an efficiency score from early refinements using 299	
cryoEF (19), additional data were collected at 26˚ using EPU software (FEI). A nominal 300	
magnification of 165,000x was used for data collection, corresponding to a pixel size of 0.865 Å 301	
at the specimen level, with the defocus ranging from -1.0 µm to -3.0 µm. Movies were recorded 302	
in superresolution mode, with a total dose of ~40 e-/ Å2 , fractioned into 20 frames (0˚ tilt 303	
images) or 40 frames (26˚ tilt images) under the does rate of 8.4 electron per pixel per second.  304	
 305	
Image processing and structure analysis 306	
Movies were decompressed and gain corrected with IMOD (32). Motion correction was 307	
performed using program MotionCor2 (33), and exposure filtered in accordance with relevant 308	
radiation damage curves (34). Micrographs with high CTF Figure of Merit scores and a 309	
maximum resolution great than 3.6 Å were selected for further processing. Particles were 310	
autopicked using 2D classes as references and extracted in RELION (35) and initial 2D 311	
classification was performed in cryoSPARC (36). High quality 2D classes were selected for 312	
further processing. The initial model was de novo generated and subsequent 3D refinement were 313	
performed using cryoSPARC. The UCSF PyEM package (https://github.com/asarnow/pyem) 314	
script was used to convert the cryoSPARC coordinates into Relion. Duplicate particles were 315	
removed and particles were analyzed by 3D refinement, Bayesian Particle Polishing and CTF 316	
Refinement in Relion. The data were binned to 1.5 Å/pixel, refined with D2 symmetry, and 317	
symmetry expanded. Symmetry expanded particles were used in 3D classification without 318	
alignment. All reconstructions were analyzed using USCF Chimera. The initial model was built 319	
rigidly docking individual protein structures into the EM map using Chimera. The model was 320	
then fit and adjusted manually in USCF Chimera and Coot (37). The figures were generated 321	
using UCSF Chimera, and local resolution and final Fourier shell correlation were calculated 322	
using ResMap (38) and cryoSPARC.  323	
 324	
Data deposition 325	
Density map of GFP:DARPin-aldolase complex has been deposited in the Electron Microscopy 326	
Data Bank (EMDB) with access code: EMD-9277 and PDB 6MWQ.  327	
 328	
 329	
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Figure captions 339	
 340	
Fig 1. The Design of the platform.  341	
(A) The platform base was homotetrameric rabbit muscle aldolase (PDB ID code 5VY5). One 342	
subunit was depicted with rainbow coloring and N and C labels to indicate the orientation of the 343	
monomer chain. The other three identical subunits are shown in yellow. Aldolase has D2 344	
symmetry. (B) The selectable adapter was a Designed Ankyrin Repeat Protein (DARPin) (PDB 345	
ID Code 5MA6). A DARPin is made up of a series of ankyrin repeat motifs (a beta turn followed 346	
by two antiparallel alpha helices). Here a DARPin against GFP was used. The general structure 347	
of the library this DARPin came from is an N-terminal cap (red) followed by a series of internal 348	
binding modules (here module 1 (orange), module 2 (yellow) and module 3 (green)) that are 349	
stabilized by a C-terminal cap (blue) (12). Shown below is a close-up view of the repetitive motif 350	
of DARPin with its amino acid sequence (orange). Using a phage display library, DARPins can 351	
be generated against a protein target. The selectable residues are depicted in black as X (any 352	
amino acid except cysteine or proline) or Z (amino acids asparagine, histidine or tyrosine) (12). 353	
(C) The final helix of the C-terminal cap of the DARPin (orange) was directly fused to the first 354	
alpha helix of aldolase (yellow) to form the platform subunit. (D) The D2 symmetry of the 355	
DARPin-aldolase fusion demonstrates ample space for target binding. (E) Spheres (radius=60 Å) 356	
were drawn in the position where each DARPin binds its target. A globular protein of up to 740 357	
kDa could be accommodated on the DARPin-aldolase platform without steric clash. (F) The 358	
model of the DARPin-aldolase platform in complex with GFP (green) is shown.  359	
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 360	
Fig 2. The cryoEM structure of the DARPin-aldolase platform in complex with the target 361	
GFP  362	
(A) Surface of the 3 Å C1 reconstruction of DARPin-aldolase platform in complex with GFP. 363	
The crystal structures of GFP (green), the DARPin (orange) and aldolase (yellow) were docked 364	
into the cryoEM density. Shown on the left is the overall structure and on the right is the 365	
expanded view of GFP and the DARPin fit into the density of the best resolved subunit. The 366	
expanded view in the dashed line box is shown from the top (left) and halfway down the 367	
DARPin with clipping (right) to indicate the quality of the fit. (B) Ribbon diagram (left) and 368	
cryoEM density (right, blue mesh, zoned 1.8 Å within atoms) of an internal aldolase helix 369	
(residues Arg369 to Asp387). (C) Ribbon diagram (left) and cryoEM density (right, blue mesh, 370	
zoned 1.8 Å within atoms) of the helical linker (residues Ala176 to Ile191) between the DARPin 371	
(orange, residues Ala176 to Lys181) and aldolase (yellow, residues Leu182 to Ile191). (D) 372	
ResMap local resolution estimate of the final DARPin-aldolase platform in complex with GFP 373	
(left) and of the best subunit (right). The expanded view in the dashed line box is shown from the 374	
side (left) and halfway into the GFP:DARPin density with clipping (right).  375	
 376	
Fig 3. Symmetry expanded 3D classification of the GFP:DARPin region of the density.  377	
(A) CryoEM density of the D2 reconstruction of the DARPin-aldolase platform in complex with 378	
GFP (grey) is shown with a mask (pink) around one GFP:DARPin region. Symmetry expansion 379	
was applied to this particle set so that each GFP:DARPin region in each tetramer could be 380	
considered independently in 3D classification. (B) 3D classification without alignment of the 381	
symmetry expanded particles yielded five reasonable classes. The number of particles per class is 382	
indicated above each class. Each density was viewed at the same threshold in Chimera to 383	
facilitate direct comparisons. (C) The classes in Fig 3B were each compared with Class 4 (grey) 384	
to show the displacement between classes. The XZ plane is shown and the Y axis is 385	
perpendicular to the page. Class 4 was clearly displaced relative to the other classes. (D) The 386	
comparison from Fig 3B is now viewed looking down the Z axis. (E) The view from Fig 3D was 387	
adjusted to look down the helical linker. Residue Arg190, the C-cap helix 1, and the binding 388	
module 3 are labeled with arrows to orient the reader relative to Fig 1.  389	
 390	
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Supporting information 392	
 393	
S1 Fig. Attempted platform designs and outcomes 394	
(A) Models of the seven platform base proteins tested here. Different subunits of the platform 395	
were drawn by different colors. The fused DARPin (in green) and target GFP (in cyan) were 396	
shown for only one subunit for clarity. (B) Table summarizing the progress and problems related 397	
to our designs  398	
 399	
S2 Fig. Sequence of DARPin-aldolase fusion and the purification of GFP-DARPin-aldolase 400	
complex 401	
(A) The amino acid sequence of DARPin-aldolase fusion is colored with the DARPin sequence 402	
in brown and the aldolase sequence in green. The residues that were randomized in the phage 403	
display library are colored in red. The secondary structures are indicated on top of the sequence 404	
with α-helix in magenta tubes and β-strand in green arrows. The rigid helical linker is 405	
represented by a blue tube. (B) Gel filtration chromatography of the purified DARPin-aldolase 406	
platform in complex with GFP on Superdex 200 column. The black arrows mark the molecular 407	
weight calibration and void volume. Fractions 1 to 5 are labeled. (C) SDS-Page gel stained with 408	
Coomassie Blue of fractions 1 to 5 from the gel filtration chromatography. The bands 409	
representing the DARPin aldolase platform subunit and the GFP are labeled.  410	
 411	
S3 Fig. Major steps of the last cycle of cryoEM data processing  412	
 413	
S4 Fig. Raw micrographs with CTF correction at 0˚ and 26˚ tilt  414	
(A)-(C) Motion-corrected, dose weighted micrograph of DARPin-aldolase platform in complex 415	
with GFP in vitreous ice is acquired at a nominal magnification of 165,000× (left) with the 416	
Fourier transformation (inset) and the CTFFind4 plot result (right).  Micrographs were collected 417	
at 0˚ tilt in the first session (A), at 0˚ tilt in the second session (B) and at 26˚ tilt in the third 418	
session (C).  Each micrograph has been low-pass filtered to 10 Å to enhance the contrast. The 419	
power spectrum of this micrographs is shown as an inset.  CTF estimation fit (orange line) to 420	
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experimental power spectrum (green line) and quality of fit (blue line) are plotted against spatial 421	
frequency (1/Å). Scale bar, 20 nm.  422	
 423	
S5 Fig. 2D classes and FSC from the DARPin-aldolase platform in complex with GFP 424	
refinement  425	
(A) Representative 2D classification results from Relion.  (B) Relion Post Processing Fourier 426	
Shell Correlation (FSC) plot for the C1 refinement of the DARPin-aldolase platform in complex 427	
with GFP.  A B factor of -75 Å2 was used to sharpen the map.  FSC for the phase randomized 428	
masked map (red), the unmasked map (green), the masked map (blue) and the corrected map 429	
(black) are plotted.  The FSC=0.143 cutoff is annotated with a black horizontal line.   430	
 431	
S6 Fig. 3D classification without alignment of the symmetry expanded class 2.  432	
Class 2 (yellow, top row) from the 3D classification discussed in Fig 3 contained over 50% of 433	
the particles and appeared to lack a DARPin, so it was selected for an additional round of 3D 434	
classification without alignment.  The resulting five classes (bottom row) show low resolution 435	
density in the GFP:DARPin region of the map.   436	
 437	
S1 Movie. 438	
Model of the DARPin-aldolase platform in complex with four spheres (radius=60 Å) anchored at 439	
the DARPin binding sites.  440	
 441	
S2 Movie. 442	
ResMap local resolution estimation of the DARPin-aldolase platform in complex with GFP.  443	
 444	
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